From October 1, 2022 to December 31, 2022, the company has repurchased 5,409,000 shares, representing 0.49% for CNY 45.67 million. With this, the company has completed the repurchase of 33,001,600 shares, representing 2.97% for CNY 289.98 million under the buyback announced on April 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.79 CNY | -3.14% | -5.96% | -36.95% |
Jun. 18 | Jinyu Bio-Technology's Unit Gets Nod to Produce Triple Cat Vaccine | MT |
May. 28 | China Issues Temporary Approval for Jinyu's Inactivated Bovine Nodular Dermatosis Vaccine | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.95% | 1.08B | |
-11.03% | 80.13B | |
-5.17% | 6.98B | |
+19.62% | 3.59B | |
-1.95% | 3.15B | |
+11.49% | 1.67B | |
-7.81% | 1.19B | |
-38.79% | 1.05B | |
-34.49% | 875M | |
-19.52% | 861M |
- Stock Market
- Equities
- 600201 Stock
- News Jinyu Bio-technology Co., Ltd.
- Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announced on April 8, 2022.